Medicabil Logo
Blog Posts

What Is Chronic Thromboembolic Pulmonary Hypertension? What Are Its Symptoms? How Is It Treated?

Created17.09.2026 09:16:03
·
Last Updated17.09.2026 09:17:53
·
Medical Review17.09.2026
·
·

Chronic Thromboembolic Pulmonary Hypertension: What Is It, Symptoms, and Treatment

In this article, we will examine the details of chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is high blood pressure in the small blood vessels of the lungs caused by blood clots and scar tissue. While it can affect anyone, CTEPH is often curable.

What Is Chronic Thromboembolic Pulmonary Hypertension? CTEPH is a rare form of pulmonary hypertension characterized by abnormally high pressure in the small blood vessels of the lungs. This elevated pressure stems from previous blood clots that formed in the lungs.

Who Gets CTEPH? CTEPH occurs exclusively in individuals with a history of blood clots in the lungs (pulmonary embolism). High pressure in the lung vessels without a prior pulmonary embolism indicates a different medical condition.

How Common Is CTEPH? The estimated annual incidence in the general population is 3 to 30 new cases per million, with a prevalence of 25 to 38 cases per million. However, because the condition is frequently underdiagnosed or misdiagnosed, actual numbers are believed to be higher.

How Does CTEPH Affect the Body? In CTEPH, pressure rises on the right side of the heart, causing oxygen-depleted blood to back up. As a result, the heart must work harder to pump blood through the lungs, and transit time through pulmonary vessels increases, leading to lower oxygen levels.

Causes of CTEPH CTEPH develops when small blood clots in the pulmonary arteries fail to dissolve, eventually forming scar-like tissue that narrows the blood vessels. Greater narrowing leads to higher vascular pressure.

Risk Factors

  • Having a non-O blood type
  • Bone infection (osteomyelitis)
  • Certain types of cancer
  • Chronic gastrointestinal diseases, such as inflammatory bowel disease
  • Female sex
  • Infection of heart tissue related to a pacemaker
  • Personal or family history of blood clots or clotting disorders, including antiphospholipid syndrome
  • Previous surgical removal of the spleen (splenectomy)
  • Thyroid hormone replacement therapy

Symptoms of CTEPH

  • Chest pain or tightness
  • Coughing up blood (hemoptysis; rare)
  • Bluish discoloration of the fingers and toes (cyanosis)
  • Dizziness or lightheadedness
  • Fainting (syncope)
  • Fatigue
  • Heart palpitations
  • Shortness of breath (dyspnea), particularly during physical activity
  • Swelling in the legs due to fluid retention (edema)

Diagnosis Diagnostic evaluation typically begins with screening tests, including:

  • Ventilation-perfusion (V/Q) lung scan
  • Pulmonary angiography (to visualize blood clots or narrowed vessels)
  • Pulmonary function tests
  • Transthoracic echocardiogram (TTE)

Additional tests are usually required to confirm the diagnosis and assess disease severity:

  • Right heart catheterization
  • CT pulmonary angiography or digital subtraction angiography
  • Magnetic resonance imaging (MRI)
  • Exercise stress testing

Interventional Treatments Primary treatment requires interventional procedures:

  • Pulmonary Endarterectomy (PEA): An open surgical procedure that removes blood clots and scar tissue from the pulmonary arteries.
  • Balloon Pulmonary Angioplasty (BPA): A catheter-based procedure using tiny balloons to push scar tissue aside and open narrowed arteries.

Medical Management Riociguat tablets may help alleviate symptoms in individuals who are not candidates for surgery or catheter interventions, or in those with persistent pulmonary hypertension following surgical treatment.

Prognosis Pulmonary endarterectomy and balloon pulmonary angiography can potentially cure CTEPH, offering an excellent long-term prognosis. Because anxiety and depression are common—especially among those unable to undergo curative interventions—patients are encouraged to discuss mental health concerns with their doctor.

Prevention and Management While many underlying risk factors are beyond individual control, avoiding tobacco use and quitting smoking can support overall lung health.

Living with CTEPH requires lifelong blood thinner (anticoagulant) therapy. Patients taking warfarin may need to manage their intake of vitamin K–rich foods, such as soy and broccoli. Light exercise, such as walking or structured pulmonary rehabilitation under medical supervision, can help improve strength and overall well-being.

CTEPH is a rare but treatable form of pulmonary hypertension. With timely interventional treatment, many patients achieve full recovery and excellent outcomes.Would you like to discuss the procedural details or eligibility criteria for pulmonary endarterectomy (PEA) versus balloon pulmonary angioplasty (BPA)?

Ask Our Experts

Fill out the form below to ask our experts a question.

I consent to the recording of my personal data and contact information provided during the registration process by Medicabil Private Hospital within the scope of the Personal Data Protection Law No. 6698 (). KVKK
Contact via WhatsAppReach our experts quickly via WhatsApp.
WhatsApp